Bixiye
QP11-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Natiijooyinka Raadinta
Soo bandhiga 1521 - 1530 ee natiijooyinka 4162
Bixiye
QP10-21 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 100-150 mg, 133-200 mg, and 167-250 mg
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP12-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
P73-20 2021 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020
Bixiye
P72-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020
Bixiye
P74-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 30, 2020
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020
Bixiye
P75-20 Removal of Six Commercial Prior Authorization Requirements—Effective November 16, 2020
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020
Bixiye
QP91-20 MHCP Pharmacy Benefit Exclusion for Tecartus™, Monjuvi™ and Blenrep
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 23, 2020
Bixiye
QP93-20 Prior Authorizations for Drugs
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 23, 2020